Proceedings of the 1st Puerto Rico Biobanking Workshop
- 6 March 2015
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Reviews on Recent Clinical Trials
- Vol. 9 (4), 233-244
- https://doi.org/10.2174/1574887110666150127105545
Abstract
The 1st Puerto Rico Biobanking Workshop took place on August 20st, 2014 in the Auditorium of the Comprehensive Cancer Center of the University of Puerto Rico, Medical Sciences Campus in San Juan Puerto Rico. The program for this 1-day, live workshop included lectures by three biobanking experts, followed by presentations from existing biobanks in Puerto Rico and audience discussion. The need for increasing biobanking expertise in Puerto Rico stems from the fact that Hispanics in general are underrepresented in the biobanks in existence in the US, which limits the research conducted specifically to understand the molecular differences in cancer cells compared to other better studied populations. In turn, this lack of information impairs the development of better diagnostic and therapeutic approaches for our population. Dr. James Robb, M.D., F.C.A.P., consulting pathologist to the National Cancer Institute (NCI) and the Office of Biorepositories and Biospecimen Research (OBBR), opened the workshop with a discussion on the basic aspects of the science of biobanking (e.g., what is a biobank; its goals and objectives; protocols and procedures) in his talk addressing the importance of banking tissues for advancing biomedical research. Next, Dr. Gustavo Stefanoff, from the Cancer Institutes Network of Latin America (RINC by its name in Spanish), explained the mission, objectives, and structure of the Network of Latin-American and Caribbean Biobanks (REBLAC by its name in Spanish), which despite limited resources and many challenges, currently accrue high quality human tissue specimens and data to support cancer research in the region. Dr. Robert Hunter-Mellado, Professor of Internal Medicine, Universidad Central del Caribe, followed with an examination of the ethical and regulatory aspects of biobanking tissues for future research, including informed consent of subjects; protection of human subjects rights; and balancing risks and benefit ratios. In the afternoon, the directors of existing biobanks in Puerto Rico (the Puerto Rico Biobank, the Comprehensive Cancer Center biobank, and an HIV-focused biobank at Universidad Central del Caribe) presented their experiences and challenges with establishing biobanks for research in Puerto Rico. In sum, this workshop presented opportunities to share knowledge in the science of biobanking, for further training, and of networking among the participants (34 from 4 different institutions), which will strengthen the collaborative links between investigators studying cancer in Latin America, the Caribbean, and the US.This publication has 15 references indexed in Scilit:
- Principles of Analytic Validation of Immunohistochemical Assays: Guideline From the College of American Pathologists Pathology and Laboratory Quality CenterArchives of Pathology & Laboratory Medicine, 2014
- A Call to Standardize Preanalytic Data Elements for BiospecimensArchives of Pathology & Laboratory Medicine, 2014
- The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settingsClinical Biochemistry, 2014
- Evaluation of DNAstable™ for DNA storage at ambient temperatureForensic Science International: Genetics, 2014
- Biobanking: The Melding of Research with Clinical CareCurrent Genetic Medicine Reports, 2013
- Noninvasive Quality Control of Cryopreserved SamplesBiopreservation and Biobanking, 2012
- Biospecimens and Biorepositories for the Community PathologistArchives of Pathology & Laboratory Medicine, 2012
- Delay to formalin fixation effect on breast biomarkersLaboratory Investigation, 2009
- Assessment of a HER2 scoring system for gastric cancer: results from a validation studyHistopathology, 2008
- Clinical importance of HER2 immunohistologic heterogeneous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) casesLaboratory Investigation, 2008